38 related articles for article (PubMed ID: 29410238)
1. Clonality and altered behavior of endothelial cells from hemangiomas.
Boye E; Yu Y; Paranya G; Mulliken JB; Olsen BR; Bischoff J
J Clin Invest; 2001 Mar; 107(6):745-52. PubMed ID: 11254674
[TBL] [Abstract][Full Text] [Related]
2. pH-Responsive Nanostructures Based on Surface Active Fatty Acid-Protic Ionic Liquids for Imiquimod Delivery in Skin Cancer Topical Therapy.
Tampucci S; Guazzelli L; Burgalassi S; Carpi S; Chetoni P; Mezzetta A; Nieri P; Polini B; Pomelli CS; Terreni E; Monti D
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33187215
[TBL] [Abstract][Full Text] [Related]
3. Non-Invasive Analysis of Actinic Keratosis before and after Topical Treatment Using a Cold Stimulation and Near-Infrared Spectroscopy.
Seoni S; Savoia P; Veronese F; Zavattaro E; Tarantino V; Meiburger KM
Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32967260
[No Abstract] [Full Text] [Related]
4. Progress in the treatment of infantile hemangioma.
Chen ZY; Wang QN; Zhu YH; Zhou LY; Xu T; He ZY; Yang Y
Ann Transl Med; 2019 Nov; 7(22):692. PubMed ID: 31930093
[TBL] [Abstract][Full Text] [Related]
5. The Role of Toll-Like Receptors in Oncotherapy.
Liu C; Han C; Liu J
Oncol Res; 2019 Aug; 27(8):965-978. PubMed ID: 30940297
[TBL] [Abstract][Full Text] [Related]
6. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases.
Senchak AJ; Dann M; Cable B; Bessinger G
Ear Nose Throat J; 2010 Mar; 89(3):E21-5. PubMed ID: 20229466
[TBL] [Abstract][Full Text] [Related]
8. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
Ho NT; Lansang P; Pope E
J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
[TBL] [Abstract][Full Text] [Related]
9. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream.
Hazen PG; Carney JF; Engstrom CW; Turgeon KL; Reep MD; Tanphaichitr A
Pediatr Dermatol; 2005; 22(3):254-6. PubMed ID: 15916578
[TBL] [Abstract][Full Text] [Related]
10. Ulcerated infantile hemangioma treated with imiquimod.
Mascarenhas R; Guiote V; Agro J; Henrique M
Dermatol Online J; 2011 Sep; 17(9):13. PubMed ID: 21971278
[TBL] [Abstract][Full Text] [Related]
11. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma.
McCuaig CC; Dubois J; Powell J; Belleville C; David M; Rousseau E; Gendron R; Jafarian F; Auger I
Pediatr Dermatol; 2009; 26(2):203-12. PubMed ID: 19419474
[TBL] [Abstract][Full Text] [Related]
12. Selective hemangioma cell dysfunction and apoptosis triggered by in vitro treatment with imiquimod.
Rocco R; Alegre N; Pozner R; Wainstok R; Gazzaniga S
Toxicol Lett; 2018 May; 288():82-88. PubMed ID: 29410238
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod - Its role in the treatment of cutaneous malignancies.
Bubna AK
Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
